Supporting the putative oncogenic activity of HDAC4, mouse models with deregulated class IIa HDACs-HDAC7 or HDAC9-have been reported to develop cancer (Rad et al., 2010; Gil et al., 2016). This evidence concerns the gene HDAC4 and cancer.